Hospital-acquired infection outbreak thresholds: Difference between revisions
From IDWiki
m (Aidan moved page Infection Prevention and Control Outbreak thresholds to Hospital-acquired infection outbreak thresholds without leaving a redirect) |
m (Formatted links) |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{| class="wikitable" |
|||
= Outbreak thresholds = |
|||
! Organism !! Definition !! Incubation !! Point prevalence testing |
|||
{| |
|||
! Organism |
|||
! Definition |
|||
! Incubation |
|||
! Point prevalence testing |
|||
|- |
|- |
||
| [[Enterococcus species|VRE]] |
|||
| VRE |
|||
| 3 noso cases in 7 days, or 5 in 28 days |
| 3 noso cases in 7 days, or 5 in 28 days |
||
| — |
| — |
||
| Test 3 days, 3 days, and 7 days |
| Test 3 days, 3 days, and 7 days |
||
|- |
|- |
||
| [[Staphylococcus aureus|MRSA]] |
|||
| MRSA |
|||
| As above |
| As above |
||
| — |
| — |
||
| Line 22: | Line 17: | ||
| Weekly or at discretion of ICP |
| Weekly or at discretion of ICP |
||
|- |
|- |
||
| C. difficile |
| [[Clostridioides difficile|''C. difficile'']] |
||
| For >20 beds: 3 noso cases in 7 days, or 5 in 28 days<br/>For <20 beds: 2 noso cases in 7 days, or 4 in 28 days |
| For >20 beds: 3 noso cases in 7 days, or 5 in 28 days<br/>For <20 beds: 2 noso cases in 7 days, or 4 in 28 days |
||
| — |
| — |
||
| Line 32: | Line 27: | ||
| Ongoing syrveillance for symptomatic patients and staff |
| Ongoing syrveillance for symptomatic patients and staff |
||
|- |
|- |
||
| Norovirus |
| [[Norovirus]] |
||
| 2-3 noso cases |
| 2-3 noso cases |
||
| 2 days |
| 2 days |
||
| Ongoing surveillance for symptomatic patients and staff |
| Ongoing surveillance for symptomatic patients and staff |
||
|- |
|- |
||
| Scabies |
| [[Sarcoptes scabiei|Scabies]] |
||
| 1-2 noso cases |
| 1-2 noso cases |
||
| 6 weeks |
| 6 weeks |
||
| Ongoing surveillance for symptomatic patients and staff |
| Ongoing surveillance for symptomatic patients and staff |
||
|} |
|} |
||
[[Category:Infection prevention and control]] |
|||
Latest revision as of 13:40, 31 October 2019
| Organism | Definition | Incubation | Point prevalence testing |
|---|---|---|---|
| VRE | 3 noso cases in 7 days, or 5 in 28 days | — | Test 3 days, 3 days, and 7 days |
| MRSA | As above | — | Weekly or at discretion or ICP |
| Other ARO | As above | — | Weekly or at discretion of ICP |
| C. difficile | For >20 beds: 3 noso cases in 7 days, or 5 in 28 days For <20 beds: 2 noso cases in 7 days, or 4 in 28 days |
— | Ongoing surveillance for symptomatic patients |
| Respiratory viruses | 2+ noso cases within 48 hours on a single unit, confirmed as the same pathogen Consider enhanced monitoring if only one case was confirmed by the lab |
3 days | Ongoing syrveillance for symptomatic patients and staff |
| Norovirus | 2-3 noso cases | 2 days | Ongoing surveillance for symptomatic patients and staff |
| Scabies | 1-2 noso cases | 6 weeks | Ongoing surveillance for symptomatic patients and staff |
